Patient and prescriber characteristics among patients with type 2 diabetes mellitus continuing or discontinuing sulfonylureas following insulin initiation: data from a large commercial database.

CONCLUSIONS: About half of commercially-insured T2DM patients discontinued SU within one year after insulin initiation, and SU discontinuation was not strongly associated with a range of patient and provider characteristics. PMID: 29264933 [PubMed - as supplied by publisher]
Source: Current Medical Research and Opinion - Category: Research Tags: Curr Med Res Opin Source Type: research